ANCA-associated pauci-immune necrotizing glomerulonephritis during the treatment with pembrolizumab
Sign Up to like & getrecommendations! Published in 2020 at "Virchows Archiv"
DOI: 10.1007/s00428-020-02882-w
Abstract: Cancer immunotherapy is rapidly changing the treatment paradigm in oncology, and immune checkpoint inhibitors (ICPIs) have been used successfully in a variety of cancer types. Specific side effects termed immune-related adverse events (irAEs) have now… read more here.
Keywords: associated pauci; treatment; treatment pembrolizumab; glomerulonephritis ... See more keywords
Complete response of squamous cell carcinoma of the lung following treatment with pembrolizumab in an elderly patient: A case report
Sign Up to like & getrecommendations! Published in 2020 at "Thoracic Cancer"
DOI: 10.1111/1759-7714.13733
Abstract: Complete response of non–small cell lung cancer (NSCLC) with immune checkpoint inhibitor (ICI) monotherapy is rare. Here, we encountered an elderly patient who showed complete response of NSCLC following treatment with pembrolizumab. An 84‐year‐old man… read more here.
Keywords: treatment; lung; treatment pembrolizumab; cell ... See more keywords